| scholarly article | Q13442814 |
| P2093 | author name string | Quan Zhang | |
| Priya S Kishnani | |||
| Baodong Sun | |||
| Chunyu Yang | |||
| Haiqing Yi | |||
| P2860 | cites work | A rapid enzymic method for glycogen estimation in very small tissue samples | Q71626462 |
| Surprises of genetic engineering: a possible model of polyglucosan body disease | Q95721485 | ||
| Clinical and metabolic correction of pompe disease by enzyme therapy in acid maltase-deficient quail | Q24564823 | ||
| Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II | Q28592264 | ||
| Abnormal cardiac development in the absence of heart glycogen | Q28594636 | ||
| Insulin control of glycogen metabolism in knockout mice lacking the muscle-specific protein phosphatase PP1G/RGL. | Q30453548 | ||
| A novel mouse model that recapitulates adult-onset glycogenosis type 4 | Q30673108 | ||
| High-level production of recombinant human lysosomal acid alpha-glucosidase in Chinese hamster ovary cells which targets to heart muscle and corrects glycogen accumulation in fibroblasts from patients with Pompe disease | Q33598299 | ||
| Glycogen metabolism and glycogen-storage diseases | Q34059911 | ||
| Lafora's disease: towards a clinical, pathologic, and molecular synthesis | Q34085650 | ||
| Adult polyglucosan body disease: Natural History and Key Magnetic Resonance Imaging Findings | Q34303763 | ||
| Branching enzyme-deficiency glycogenosis: studies in therapy | Q36061863 | ||
| Characterization of a canine model of glycogen storage disease type IIIa | Q36359220 | ||
| Lack of an alpha-1,4-glucan: alpha-1,4-glucan 6-glycosyl transferase in a case of type IV glycogenosis | Q36462030 | ||
| Enhanced response to enzyme replacement therapy in Pompe disease after the induction of immune tolerance | Q36492202 | ||
| Comparison of direct and indirect methods of carrier detection in an X-linked disease | Q43588239 | ||
| Overexpression of glycogen synthase in mouse muscle results in less branched glycogen | Q44454793 | ||
| Enzyme replacement therapy in the mouse model of Pompe disease | Q44624370 | ||
| Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia. | Q45417049 | ||
| Correction of glycogen storage disease type II by an adeno-associated virus vector containing a muscle-specific promoter | Q45457148 | ||
| Correction of glycogen storage disease type III with rapamycin in a canine model | Q48889382 | ||
| Polyglucosan neurotoxicity caused by glycogen branching enzyme deficiency can be reversed by inhibition of glycogen synthase. | Q51052738 | ||
| Adult polyglucosan body disease in Ashkenazi Jewish patients carrying the Tyr329Ser mutation in the glycogen-branching enzyme gene | Q55670773 | ||
| Simple enzymatic determination of polysaccharide (glycogen) content of animal tissues | Q68926872 | ||
| The fine structure of glycogen from type IV glycogen-storage disease | Q71028524 | ||
| P921 | main subject | glycogen storage disease | Q1421738 |
| glycogen metabolic process | Q14902477 | ||
| P304 | page(s) | 89-94 | |
| P577 | publication date | 2016-06-26 | |
| P1433 | published in | Journal of Inherited Metabolic Disorders Reports | Q27724122 |
| P1476 | title | A Modified Enzymatic Method for Measurement of Glycogen Content in Glycogen Storage Disease Type IV. | |
| P478 | volume | 30 |
| Q39285384 | Alglucosidase alfa treatment alleviates liver disease in a mouse model of glycogen storage disease type IV. | cites work | P2860 |
Search more.